ETFSPDR S&P Biotech ETFXBI

XBI

SPDR S&P Biotech ETF

73.55 -0.51 (-0.68%)
Forsinkede priser fra NASDAQ i USD Marked åbent
Handl
S
73.55
K
73.71
Top
Yannic Stollenmaier
The value of all publicly traded biotech companies has fallen by over 70% in the last 18 months. Many biotech companies are currently struggling to survive because they desperately need new money, but unlike in the past, there is no more money. Therefore, without revenues and earnings, many are likely... Vis Oversæt
Synes godt om KommentarDel
null
.
Eugenio Gallegos Deveze
Redigeret
WEEKLY UPDATE as of close June 24 Hello copiers and followers! This week we did well 💰🤑 through shorts in the energy sectors: mainly oil, gas and companies in the sector where we took advantage of the fall and shorts in copper mining, On the part of the investments on the long side at the end of... Vis Oversæt
Synes godt om KommentarDel
Vis flere kommentarer2 af 3
7 svar
1 svar
null
.
Simone Rizzetto
Update: Inflation keeps running high and expectation of a recession triggered by rising interest rate is increasing. In the past days market started to price in the higher likelihood of a recession in 2023. Regardless or not there will be a recession biotech stocks are deeply undervalued. These are... Vis Oversæt
Synes godt om KommentarDel
null
.
VolatilityAlerts
$XBI rises 7.0% - Is it time to buy or sell? Oversæt
XBI
SPDR S&P Biotech ETF
73.55
-0.51 (-0.68%)
Handl
Yannic Stollenmaier
There it is, the bear market. $SPX500 compared to the closing price high of 03.01.2022 now 21.8% in the red. Yesterday was the first day in 32 years that all 500 stocks in the index were down at the same time (during trading). At -20.8%, this is the worst start to a year in 82 years. The underwater... Vis Oversæt